Biography
Susan Ribeiro, PhD, is an assistant professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine in Atlanta, Georgia.
Dr. Ribeiro is a member of the Cancer Immunology Research Program at Winship Cancer Institute. Her research focus is on infectious diseases and cancers.
Education
Dr. Ribeiro obtained her PhD from the School of Medicine at the University of Sao Paulo in Brazil, where she also completed a postdoctoral fellowship focused on HIV vaccine development and immunogenicity evaluation in pre-clinical models (transgenic mice and rhesus macaques). She completed part of her postdoctoral training at University of California, extending her studies to HIV pathogenesis.
Titles & Roles
-
Assistant Professor, Department of Pathology and Laboratory MedicineEmory University School of Medicine
Research
Trained as a systems biologist, Dr. Ribeiro applies multi-omics platforms to understand the mechanisms underlying immune responses to diseases and immunotherapies in human cohorts. High-throughput tools are used to validate the major findings in vitro resulting in the development of specific drugs to be tested in non-human primates, being clinical trials the expected outcome.
Dr. Ribeiro was initially involved in HIV vaccine development in pre-clinical models and has expanded her research focus to system's biology. Currently, she is focused on the role of IL10 and other factors (such as microbiome, metabolome, drugs of abuse, etc) in the modulation of the immune system in HIV, cancers and COVID19.
Publications
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size. Nature immunology |
K Ghneim, F Ten-Caten, AC Santana, MB Latif, DA Diaz-Dinamarca, T García-Salum, PM Del Rio Estrada, P Sohal, Z Strongin, J Harper, S Jean, C Wallace, R Balderas, JD Lifson, G Raghunathan, E Rimmer, CV Pastuskovas, G Wu, L Micci, LF Martins Sieben, PC Lopes Gerum, J Dos Santos, MG Netea, A van der Ven, G Silvestri, DJ Hazuda, DM Gorman, BJ Howell, AA Sharma, M Paiardini, H Soudeyns, S Pereira Ribeiro, RP Sekaly | 03/20/2026 |
|
PloS one |
DB Victorino, JM Malheiros, F Ten-Caten, VH Cardoso Betta, FFS Barbosa, K Ghneim, FC Coirada, FR Bruno, GX de Medeiros, C Silveira, C Gavegnano, R Balderas, AC Brandao, E Yang, H Nakaya, GA Wagner, L Covolan, S Pereira Ribeiro | 01/01/2026 |
|
Nature immunology |
S Pereira Ribeiro, Z Strongin, H Soudeyns, F Ten-Caten, K Ghneim, G Pacheco Sanchez, G Xavier de Medeiros, PM Del Rio Estrada, AN Pelletier, T Hoang, K Nguyen, J Harper, S Jean, C Wallace, R Balderas, JD Lifson, G Raghunathan, E Rimmer, CV Pastuskovas, G Wu, L Micci, RM Ribeiro, CN Chan, JD Estes, G Silvestri, DM Gorman, BJ Howell, DJ Hazuda, M Paiardini, RP Sekaly | 10/01/2024 |
|
Pediatric immunotherapy and HIV control. Current opinion in HIV and AIDS |
TT Chinunga, A Chahroudi, SP Ribeiro | 07/01/2024 |
|
COVID-19 and Down syndrome: the spark in the fuel. Nature reviews. Immunology |
M Majithia, SP Ribeiro | 07/01/2022 |
|
Vaccine |
SP Ribeiro, VG De Moura Mattaraia, RR Almeida, EJG Valentine, NS Sales, LCS Ferreira, LC Sa-Rocha, LC Jacintho, VC Santana, J Sidney, A Sette, DS Rosa, J Kalil, E Cunha-Neto | 01/21/2022 |
|
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections. Frontiers in immunology |
MD Reece, C Song, SC Hancock, S Pereira Ribeiro, DA Kulpa, C Gavegnano | 01/01/2022 |